Carboplatin Non-Small Cell Lung Cancer trial: NCT07877584
NCT07877584 is a phase 3 NSCLC trial of PD-1 blockade with or without chemotherapy; BioQ adds carboplatin ChEMBL potency and ClinicalTrials.gov context.
BioQ Blog
Every BioQ post about NSCLC: real search results, sources and the query to repeat it.
NCT07877584 is a phase 3 NSCLC trial of PD-1 blockade with or without chemotherapy; BioQ adds carboplatin ChEMBL potency and ClinicalTrials.gov context.
One query, osimertinib, returns phase counts for 188 registered ClinicalTrials.gov studies and a status table, with EGFR drug context, as of 2026-11-06.